Attending Physician, Division of Pulmonology, University Hospital of Zurich
- 2003 obtained MD, Medical Faculty, University of Zurich
- Postgraduate Course for Experimental Medicine and Biology of the Medical Faculty at the University of Zurich (2004-2005)
- 2011 Board certification for Internal Medicine (FMH)
- 2014 Board certification for Pulmonology (FMH)
Signaling pathways involved in the pathogenesis of pulmonary hypertension. Hypoxia, Inflammation and Vascular remodelling.
FMH (Swiss Medical Association)
SGIM (Swiss Society of Internal Medicine)
SSPH (Swiss Society of Pulmonary Hypertension)
ERS (European Respiratory Society)
ACCP (American College of Chest Physician)
ISHLT (International Society for Heart & Lung Transplantation)
In the role of Faculty Member, Lars C Huber contributes recommendations and reviews to the Pulmonary Vascular Diseases Section in the Respiratory Disorders Faculty, writing brief accessible comments to summarize the value of the articles and adding rating score.
The Faculty comprises Heads of Faculty, Heads of Section, Faculty Members and Associate Faculty Members, as well as an International Advisory Board.
Read more about F1000Prime »